These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21654344)

  • 1. Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R.
    Molhoek KR; Shada AL; Smolkin M; Chowbina S; Papin J; Brautigan DL; Slingluff CL
    Melanoma Res; 2011 Aug; 21(4):274-84. PubMed ID: 21654344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth.
    Yoshida M; Selvan S; McCue PA; DeAngelis T; Baserga R; Fujii A; Rui H; Mastrangelo MJ; Sato T
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):297-308. PubMed ID: 24354797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.
    Yu L; Saile K; Swartz CD; He H; Zheng X; Kissling GE; Di X; Lucas S; Robboy SJ; Dixon D
    Mol Med; 2008; 14(5-6):264-75. PubMed ID: 18231572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody.
    Chapuis N; Tamburini J; Cornillet-Lefebvre P; Gillot L; Bardet V; Willems L; Park S; Green AS; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D
    Haematologica; 2010 Mar; 95(3):415-23. PubMed ID: 20007139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of neuroblastoma cell lines in insulin-like growth factor 1 receptor/Akt pathway-mediated cell proliferative responses.
    Qi L; Toyoda H; Shankar V; Sakurai N; Amano K; Kihira K; Iwasa T; Deguchi T; Hori H; Azuma E; Gabazza EC; Komada Y
    Cancer Sci; 2013 Sep; 104(9):1162-71. PubMed ID: 23710710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RT-PCR-based tyrosine kinase display profiling of canine melanoma: IGF-1 receptor as a potential therapeutic target.
    Thamm DH; Huelsmeyer MK; Mitzey AM; Qurollo B; Rose BJ; Kurzman ID
    Melanoma Res; 2010 Feb; 20(1):35-42. PubMed ID: 19949352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of P-Rex1 at serine 1169 participates in IGF-1R signaling in breast cancer cells.
    Montero JC; Seoane S; Pandiella A
    Cell Signal; 2013 Nov; 25(11):2281-9. PubMed ID: 23899556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-independent activation of MET through IGF-1/IGF-1R signaling.
    Varkaris A; Gaur S; Parikh NU; Song JH; Dayyani F; Jin JK; Logothetis CJ; Gallick GE
    Int J Cancer; 2013 Oct; 133(7):1536-46. PubMed ID: 23526299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine secretion of insulin-like growth factor-I mediates growth hormone-stimulated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes.
    Kurihara K; Moteki H; Kimura M; Ogihara M
    Eur J Pharmacol; 2021 Jan; 891():173753. PubMed ID: 33245901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
    Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
    Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor.
    Sprynski AC; Hose D; Caillot L; Réme T; Shaughnessy JD; Barlogie B; Seckinger A; Moreaux J; Hundemer M; Jourdan M; Meissner T; Jauch A; Mahtouk K; Kassambara A; Bertsch U; Rossi JF; Goldschmidt H; Klein B
    Blood; 2009 May; 113(19):4614-26. PubMed ID: 19228610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
    Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
    Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.
    Li M; Chiu JF; Gagne J; Fukagawa NK
    J Cell Physiol; 2008 Nov; 217(2):377-87. PubMed ID: 18615585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP secretion in human neuroblastoma cells in relation to cellular proliferation.
    Kiess W; Koepf G; Christiansen H; Blum WF
    Regul Pept; 1997 Sep; 72(1):19-29. PubMed ID: 9404729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray analysis of insulin and insulin-like growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1.
    Mulligan C; Rochford J; Denyer G; Stephens R; Yeo G; Freeman T; Siddle K; O'Rahilly S
    J Biol Chem; 2002 Nov; 277(45):42480-7. PubMed ID: 12213819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.
    Doepfner KT; Spertini O; Arcaro A
    Leukemia; 2007 Sep; 21(9):1921-30. PubMed ID: 17581609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
    Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer.
    Buck E; Gokhale PC; Koujak S; Brown E; Eyzaguirre A; Tao N; Rosenfeld-Franklin M; Lerner L; Chiu MI; Wild R; Epstein D; Pachter JA; Miglarese MR
    Mol Cancer Ther; 2010 Oct; 9(10):2652-64. PubMed ID: 20924128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.
    Worrall C; Suleymanova N; Crudden C; Trocoli Drakensjö I; Candrea E; Nedelcu D; Takahashi SI; Girnita L; Girnita A
    Oncogene; 2017 Jun; 36(23):3274-3286. PubMed ID: 28092675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression.
    Cornu M; Modi H; Kawamori D; Kulkarni RN; Joffraud M; Thorens B
    J Biol Chem; 2010 Apr; 285(14):10538-45. PubMed ID: 20145256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.